{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T10:14:53Z","timestamp":1766571293663,"version":"3.48.0"},"reference-count":33,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Department of the Navy (DoW) Grant","award":["R.0036258.5.36"],"award-info":[{"award-number":["R.0036258.5.36"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Background\/Objectives: Malignant hyperthermia (MH) is a life-threatening pharmacogenetic disorder of skeletal muscle calcium regulation and commonly associated with pathogenic variants in the RYR1 gene. Interpretation of rare RYR1 variants remains challenging, particularly when classified as variants of uncertain significance (VUS). This study describes the clinical, functional, and genetic evaluation of a patient with suspected MH susceptibility carrying a rare RYR1 mutation. Methods: We report a retrospective case evaluation of a 32-year-old female referred for MH assessment following a prior peri-operative hypermetabolic event. Clinical records were reviewed, and MH susceptibility was assessed using the caffeine\u2013halothane contracture test (CHCT). Genetic testing was performed using a targeted MH susceptibility gene panel, including RYR1, CACNA1S, and STAC3. Variant classification was conducted following American College of Medical Genetics and Genomics\/Association for Molecular Pathology (ACMG\/AMP) guidelines. Results: The patient demonstrated a positive CHCT, consistent with MH susceptibility. Genetic analysis identified a rare heterozygous RYR1 missense variant. No pathogenic or likely pathogenic variants were detected in CACNA1S or STAC3. Based on ACMG\/AMP criteria, the RYR1 p.Gln474His variant is currently classified as a VUS. However, its localization within the N-terminal regulatory region of RyR1 and concordance with abnormal CHCT findings provide supportive functional context. Conclusions: This case underscores the importance of integrating clinical history, functional contracture testing, and genetic data in the evaluation of MH susceptibility. While functional findings may support biological plausibility, definitive pathogenic classification of rare RYR1 variants requires additional segregation data or mechanistic studies.<\/jats:p>","DOI":"10.3390\/genes17010013","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T09:58:34Z","timestamp":1766570314000},"page":"13","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and Genetic Characterization of a Novel RYR1 Variant (p.Gln474His) in Malignant Hyperthermia Susceptibility"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3304-1522","authenticated-orcid":false,"given":"Erin","family":"Tracy","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd., Bethesda, MD 20814, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katelyn","family":"Mistretta","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd., Bethesda, MD 20814, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4159-1391","authenticated-orcid":false,"given":"Peter","family":"Bedocs","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd., Bethesda, MD 20814, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5726-5972","authenticated-orcid":false,"given":"Robert","family":"Vietor","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd., Bethesda, MD 20814, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2690-8178","authenticated-orcid":false,"given":"Alakesh","family":"Bera","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd., Bethesda, MD 20814, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1213\/ane.0b013e3181ac1548","article-title":"Prevalence of malignant hyperthermia due to anesthesia in New York State, 2001\u20132005","volume":"109","author":"Brady","year":"2009","journal-title":"Anesth. Analg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/ALN.0000000000000610","article-title":"Next-generation Sequencing of RYR1 and CACNA1S in Malignant Hyperthermia and Exertional Heat Illness","volume":"122","author":"Fiszer","year":"2015","journal-title":"Anesthesiology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00000542-200211000-00007","article-title":"Presence of two different genetic traits in malignant hyperthermia families: Implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility","volume":"97","author":"Monnier","year":"2002","journal-title":"Anesthesiology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1399-6576.1997.tb04820.x","article-title":"In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: Results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group","volume":"41","author":"Ording","year":"1997","journal-title":"Acta Anaesthesiol. Scand."},{"key":"ref_5","first-page":"161","article-title":"Masseter muscle rigidity and malignant hyperthermia susceptibility","volume":"65","author":"Rosenberg","year":"1986","journal-title":"Anesth. Analg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13023-015-0310-1","article-title":"Malignant hyperthermia: A review","volume":"10","author":"Rosenberg","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1213\/00000539-198304000-00007","article-title":"In vitro contracture tests for susceptibility to malignant hyperthermia","volume":"62","author":"Rosenberg","year":"1983","journal-title":"Anesth. Analg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/B978-0-444-64074-1.00038-0","article-title":"Malignant hyperthermia","volume":"157","author":"Hopkins","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1093\/hmg\/ddac145","article-title":"Updated variant curation expert panel criteria and pathogenicity classifications for 251 variants for RYR1-related malignant hyperthermia susceptibility","volume":"31","author":"Johnston","year":"2022","journal-title":"Hum. Mol. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1515\/med-2021-0396","article-title":"Atypical symptoms of malignant hyperthermia: A rare causative mutation in the RYR1 gene","volume":"17","author":"Wang","year":"2022","journal-title":"Open Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"C1094","DOI":"10.1152\/ajpcell.00173.2004","article-title":"Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling","volume":"287","author":"Weiss","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"ra68","DOI":"10.1126\/scisignal.aad9813","article-title":"An RYR1 mutation associated with malignant hyperthermia is also associated with bleeding abnormalities","volume":"9","author":"Lopez","year":"2016","journal-title":"Sci. Signal."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3233\/JND-230018","article-title":"Muscle Ultrasound Abnormalities in Individuals with RYR1-Related Malignant Hyperthermia Susceptibility","volume":"10","author":"Kruijt","year":"2023","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Silva, M.S., Nakamura, R., Arjona, M.R., Monaco, T., Malito, M.L., Sampaio, T.O., Oliveira, S.L., Magalhaes, J.S.A., Machado-Costa, M.C., and Silva, H.C.A. (2025). STAC3 gene congenital myopathy and malignant hyperthermia: A crossroads between neurology and anesthesia. Arq. Neuropsiquiatr., 83.","DOI":"10.1055\/s-0045-1806734"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/humu.23635","article-title":"STAC3 variants cause a congenital myopathy with distinctive dysmorphic features and malignant hyperthermia susceptibility","volume":"39","author":"Zaharieva","year":"2018","journal-title":"Hum. Mutat."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/FPC.0000000000000551","article-title":"Updating probability of pathogenicity for RYR1 and CACNA1S exon variants in individuals without malignant hyperthermia after exposure to triggering anesthetics","volume":"35","author":"Roberts","year":"2025","journal-title":"Pharmacogenetics Genom."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1399-0004.2001.590306.x","article-title":"Identification of the Arg1086His mutation in the alpha subunit of the voltage-dependent calcium channel (CACNA1S) in a North American family with malignant hyperthermia","volume":"59","author":"Stewart","year":"2001","journal-title":"Clin. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0887-8994(86)90078-0","article-title":"Malignant hyperthermia susceptibility in X-linked muscle dystrophies","volume":"2","author":"Natter","year":"1986","journal-title":"Pediatr. Neurol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1016\/j.bja.2019.11.009","article-title":"Do in vitro pharmacological challenge responses differ between muscle specimens from malignant hyperthermia probands and their susceptible relatives?","volume":"124","author":"Clarke","year":"2020","journal-title":"Br. J. Anaesth."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/humu.10098","article-title":"RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes","volume":"20","author":"Robinson","year":"2002","journal-title":"Hum. Mutat."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00000542-200208000-00010","article-title":"Results of contracture tests with halothane, caffeine, and ryanodine depend on different malignant hyperthermia-associated ryanodine receptor gene mutations","volume":"97","author":"Fiege","year":"2002","journal-title":"Anesthesiology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00003643-200202000-00011","article-title":"In vitro effects of 4-chloro-3-ethylphenol in skeletal muscle preparations from malignant hyperthermia susceptible and normal swine","volume":"19","author":"Gerbershagen","year":"2002","journal-title":"Eur. J. Anaesthesiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/bja\/80.3.389","article-title":"Multicentre evaluation of ryanodine contracture testing in malignant hyperthermia. The European Malignant Hyperthermia Group","volume":"80","author":"Hopkins","year":"1998","journal-title":"Br. J. Anaesth."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J. Mol. Diagn."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bja.2023.04.014","article-title":"What is malignant hyperthermia susceptibility?","volume":"131","author":"Hopkins","year":"2023","journal-title":"Br. J. Anaesth."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Kim, K., Li, H., Yuan, Q., Melville, Z., Zalk, R., des Georges, A., Frank, J., Hendrickson, W.A., Marks, A.R., and Clarke, O.B. (2024). Structural identification of the RY12 domain of RyR1 as an ADP sensor and the target of the malignant hyperthermia therapeutic dantrolene. bioRxiv.","DOI":"10.1101\/2024.10.21.619409"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/humu.20878","article-title":"Increasing the number of diagnostic mutations in malignant hyperthermia","volume":"30","author":"Levano","year":"2009","journal-title":"Hum. Mutat."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Andrade, P.V., Santos, J.M., Teixeira, A.C.B., Sogari, V.F., Almeida, M.S., Callegari, F.M., Krepischi, A.C.V., Oliveira, A.S.B., Vainzof, M., and Silva, H.C.A. (2023). Rhabdomyosarcoma Associated with Core Myopathy\/Malignant Hyperthermia: Combined Effect of Germline Variants in RYR1 and ASPSCR1 May Play a Role. Genes, 14.","DOI":"10.3390\/genes14071360"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/gim.2013.73","article-title":"ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing","volume":"15","author":"Green","year":"2013","journal-title":"Genet. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1399-6576.2006.01165.x","article-title":"Malignant hyperthermia and central core disease causative mutations in Swedish patients","volume":"51","author":"Broman","year":"2007","journal-title":"Acta Anaesthesiol. Scand."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1042\/BCJ20170282","article-title":"Reduced threshold for store overload-induced Ca(2+) release is a common defect of RyR1 mutations associated with malignant hyperthermia and central core disease","volume":"474","author":"Chen","year":"2017","journal-title":"Biochem. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","article-title":"Mutations in RYR1 in malignant hyperthermia and central core disease","volume":"27","author":"Robinson","year":"2006","journal-title":"Hum. Mutat."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/1\/13\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T10:10:24Z","timestamp":1766571024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/1\/13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["genes17010013"],"URL":"https:\/\/doi.org\/10.3390\/genes17010013","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]}}}